Advertisement
Canada markets closed

  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • CAD/USD

    0.7264
    -0.0000 (-0.00%)
     

  • CRUDE OIL

    82.71
    +0.02 (+0.02%)
     

  • Bitcoin CAD

    84,671.09
    -3,508.02 (-3.98%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,384.80
    -3.60 (-0.15%)
     

  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     

  • 10-Yr Bond

    4.5850
    -0.0740 (-1.59%)
     

  • NASDAQ futures

    17,691.50
    +33.00 (+0.19%)
     

  • VOLATILITY

    18.21
    -0.19 (-1.03%)
     

  • FTSE

    7,847.99
    +27.63 (+0.35%)
     

  • NIKKEI 225

    37,820.16
    -141.64 (-0.37%)
     

  • CAD/EUR

    0.6804
    +0.0002 (+0.03%)
     

Behind GE’s big 1-day gain; Netflix analyst upgrade

Yahoo Finance

Here is your daily dose of trending tickers, the stocks we’re following based on your Yahoo Finance ticker searches.

General Electric (GE)

GE (GE) is biding ‘so long, farewell’ to its banking arm and investors couldn't be happier. Shares popped more than 8% Friday morning, putting the industrial behemoth and original Dow (^DJI) component on track for its biggest one-day gain since November 2011.

Looking at developments, GE will sell the bulk of its assets in its GE Capital unit, which is currently as big as the nation's seventh-largest bank, and use the proceeds to fund a $50 billion buyback. GE said its intent is to create a "simpler, more valuable company" with more than 90% of its earnings generated by its industrial businesses by 2018. That’s up from 58% in 2014.

ADVERTISEMENT

Horizon Pharma (HZNP)

Meanwhile, shareholders of Horizon Pharma (HZNP) have their sights set on a promising new drug. The stock climbed 3% after Horizon Pharma received fast track designation for its new drug Actimmune used to treat Friedreich’s ataxia, an inherited disease causing nervous-system damage that often results in motor incapacitation and the use of a wheelchair.

Horizon said there are currently no FDA-approved treatments for the disorder. About one in 50,000 people is affected by this disease.

Get the Latest Market Data and News with the Yahoo Finance App

Netflix (NFLX)

Investors' love-hate relationship with Netflix (NFLX) is turning affectionate again. Shares of the Internet media titan gained a little over two percent at the open with the stock up 9% this week.

The latest advance was likely triggered by analysts at Citi, who upgraded Netflix to "buy" from "neutral," saying it doesn't share competition concerns that are currently reflected in the stock's price. Also, they noted Netflix has become disruptive in the industry – altering viewing habits. Citi’s (C) price target for Netflix is now $525 -- about 16.5% above current levels.

Those are your trending tickers. Tell us what you think in the space below or tweet us at hashtag trending tickers.

More from Yahoo Finance

Oprah, Kevin Spacey, Apple grabbing .sucks Internet names

China looks 'a lot like the U.S. in 2008'

Why nearly 200,000 of these good-paying jobs will go unfilled